Comparison on Pharmacokinetics of Atorvastatin Calcium Tablets in Human and Beagle Dogs
Xin Zhao
Abstract
Xin Zhao
Abstract
A LC-MS/MS method was established for the determination of atorvastatin(1) and its active metabolites,ortho-hydroxy-atorvastatin(2) and para-hydroxy-atorvastatin(3),in human and Beagle dog plasma after oral administration of atorvastatin calcium tablets.The pharmacokinetic parameters of 1,2 and 3 were calculated and compared.The results indicated that the parent drug 1 was the main format circulated in human bodies,and the active metabolite 3 was not detected.While in Beagle dogs,the active metabolite 2 was the main format,with co-existence of parent drug 1 accounting for 30%as well as metabolite 3 accounting for 5%.The half life time of 1 in human bodies was about three times as long as that in Beagle dogs,while its clearance in human bodies was about 65%of that in Beagle dogs.In conclusion,there were significant pharmacokinetic differences of 1 between human and Beagle dogs.Both metabolism velocity and extent of parent drug in Beagle dogs were significantly higher than those in human bodies.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A LC-MS/MS method was established for the determination of atorvastatin(1) and its active metabolites,ortho-hydroxy-atorvastatin(2) and para-hydroxy-atorvastatin(3),in human and Beagle dog plasma after oral administration of atorvastatin calcium tablets.The pharmacokinetic parameters of 1,2 and 3 were calculated and compared.The results indicated that the parent drug 1 was the main format circulated in human bodies,and the active metabolite 3 was not detected.While in Beagle dogs,the active metabolite 2 was the main format,with co-existence of parent drug 1 accounting for 30%as well as metabolite 3 accounting for 5%.The half life time of 1 in human bodies was about three times as long as that in Beagle dogs,while its clearance in human bodies was about 65%of that in Beagle dogs.In conclusion,there were significant pharmacokinetic differences of 1 between human and Beagle dogs.Both metabolism velocity and extent of parent drug in Beagle dogs were significantly higher than those in human bodies.
Key concepts: Beagle, Pharmacokinetics, Active metabolite, Metabolite, Pharmacology, Chemistry, Atorvastatin, Half-life